These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1990700)

  • 1. Lack of class II antigen expression on hepatocytes profoundly affects CTL development in vitro and in vivo.
    Clemmings SM; Alan TJ; Bumgardner GL; Ascher NL
    Transplant Proc; 1991 Feb; 23(1 Pt 1):817-8. PubMed ID: 1990700
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of class I+, class II- hepatocytes.
    Almond PS; Bumgardner GL; Chen S; Platt J; Payne WD; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):108-9. PubMed ID: 1899298
    [No Abstract]   [Full Text] [Related]  

  • 3. Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture.
    So SK; Wilkes LM; Platt JL; Ascher NL; Simmons RL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):251-2. PubMed ID: 3274778
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of canine hepatic sinusoidal lining cells in the immune response.
    Sakagami K; Higaki K; Toda K; Nakai H; Inagaki M; Oiwa T; Saito S; Matsuoka J; Orita K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):411-5. PubMed ID: 2523138
    [No Abstract]   [Full Text] [Related]  

  • 6. Recognition of MHC class I allodeterminants regulates the generation of MHC class II-specific CTL.
    McCarthy SA; Singer A
    J Immunol; 1986 Nov; 137(10):3087-92. PubMed ID: 3095422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II antigen-specific murine cytolytic T lymphocytes (CTL). II. Genuine class II specificity of Lyt-2+ CTL clones.
    Shinohara N; Hozumi N; Watanabe M; Bluestone JA; Johnson-Leva R; Sachs DH
    J Immunol; 1988 Jan; 140(1):30-6. PubMed ID: 3257229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allogeneic lymphocyte induction in vivo of highly active T-killers specific for the molecule of the H-2 class-I complex and the detection of their receptors in vitro].
    Brondz BD; Osipova TV; Skatov DV; Blandova ZK
    Tsitologiia; 1988 Oct; 30(10):1232-41. PubMed ID: 3266689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the expression of a hepatocyte-specific MHC molecule in transgenic mice on T cell tolerance.
    Jones-Youngblood SL; Wieties K; Forman J; Hammer RE
    J Immunol; 1990 Feb; 144(4):1187-95. PubMed ID: 2303705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory T cells generated in vitro to class I+, II- hepatocytes.
    Bumgardner GL; Almond PS; Chen S; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):104-5. PubMed ID: 1990489
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in surface phenotype between cytolytic and non-cytolytic CD4+ T cells. MHC class II-specific cytotoxic T lymphocytes lack Leu 8 antigen and express CD2 in high density.
    Takada S; Koide J; Engleman EG
    J Immunol; 1989 May; 142(9):3038-44. PubMed ID: 2468710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.
    Yang Y; Wilson JM
    J Immunol; 1995 Sep; 155(5):2564-70. PubMed ID: 7650386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.